Podcast

Listen to the latest episode of the ASBMB's science policy podcast with Public Affairs Director Benjamin Corb.

Find all of the Pipettes & Politics episodes on Soundcloud, or subscribe wherever you get your podcasts.

Resources

Funding agency guidance and resources

See our list of guidance and resources from the NSF, NIH, DOE and others.

Educator resources

Online teaching: Practices and resources

A collection of resources for instructors in biochemistry, molecular biology and related fields as they make a transition to remote learning.
Magazine

Online teaching quick and dirty: COVID-19 edition

An experienced teacher of online and face-to-face courses, Ana Maria Barral offers tips for those thrust into online education by school closures in response to the novel coronavirus.
Survey

Remote study sections

The coronavirus pandemic has forced federal agencies to move study sections to virtual settings, allowing reviews to continue while also allowing reviewers to follow federal guidance restricting travel and personal interactions.

In an effort to measure and understand the impact that remote peer review might have on science (positive or negative) the ASBMB encourages you to take a moment and share your thoughts and experiences regarding online study sections.

Journal of Biological Chemistry
JBC

JBC's coronavirus virtual issue presents a retrospective collection of content on coronavirus entry, proteases and host interactions to help researchers build more quickly toward therapeutic endpoints against SARS-CoV-2 and future strains.

See also...
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
ASBMB Today
Using community-organizing skills to mobilize scientists against COVID-19

As scientists look for ways to help fight the new coronavirus, a group of grad students and postdocs create a database to connect volunteers with local health departments.

A small army of researchers races to build a coronavirus interactome

Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.

Researchers retool genomics labs to provide COVID-19 testing

The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.

Closing in on the new coronavirus

The eye-catching spikes sticking out from the surface of SARS-CoV-2 may inspire new ways to prevent or treat COVID-19 infections.

Science communication in action: COVID-19 edition

Our science writers selected 10 examples of solid scicomm about the novel coronavirus.

'We are doers. We want to get involved.'

In a department that feels almost deserted, basic scientists join the COVID-19 effort.

What makes remdesivir a promising antiviral?

Clinical trials around the world are testing remdesivir, a nucleotide analog, for possible effects against the novel coronavirus. We asked some experts what makes the molecule interesting.

Roundup: How can scientists help fight COVID-19?

The COVID-19 pandemic has many people asking, "What can I do to help?" Here, we round up a list of actions that research scientists can take.

Life in the time of COVID-19

We asked ASBMB members how the pandemic is affecting them personally and professionally. Here are their dispatches.

Study sheds light on how a drug being tested in COVID-19 patients works

As hospitalized COVID-19 patients undergo experimental therapy, research published in the Journal of Biological Chemistry explains how the drug, remdesivir, stops replication in coronaviruses.

Could an old malaria drug help fight the new coronavirus?

As new cases of the novel coronavirus appear daily, researchers in China have found that two drugs, chloroquine and remdesivir, can inhibit its replication in cell culture.